Kiran Naqvi Selected Research

Kiran Naqvi Research Topics

Disease

20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2016
11	Neoplasms (Cancer) 02/2023 - 08/2011
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2023 - 01/2018
9	Leukemia 01/2023 - 08/2011
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 01/2018
4	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2021 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 01/2018
3	Primary Myelofibrosis (Myelosclerosis) 11/2021 - 08/2011
2	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2021
2	Acute Promyelocytic Leukemia 01/2020 - 01/2019
2	Pleural Effusion (Pleural Effusions) 01/2020 - 01/2018
1	Pain (Aches) 07/2022
1	Confusion (Bewilderment) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Emergence Delirium 01/2022
1	Delirium 01/2022
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 01/2021
1	Fatigue 01/2021
1	Exanthema (Rash) 01/2021
1	Neutropenia 01/2021
1	Philadelphia Chromosome 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020
1	Disease Resistance 01/2019
1	Myeloid Sarcoma (Chloroma) 01/2018
1	Multiple Myeloma 01/2018
1	Splenomegaly 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 08/2011

Drug/Important Bio-Agent (IBA)

9	venetoclaxIBA 01/2023 - 01/2020
4	ruxolitinibIBA 11/2021 - 08/2011
3	Azacitidine (5 Azacytidine)FDA Link 02/2023 - 11/2021
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 11/2021 - 12/2019
3	Dasatinib (BMS 354825)FDA Link 01/2020 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2019 - 08/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 11/2021
2	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2018
2	Decitabine FDA Link 01/2021 - 01/2020
2	bcr-abl Fusion ProteinsIBA 01/2020 - 01/2020
2	Arsenic Trioxide (Trisenox)FDA Link 01/2020 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 11/2019 - 01/2019
1	pegaspargase (Oncaspar)FDA Link 11/2023
1	Glutamine (L-Glutamine)FDA Link 02/2023
1	GlutaminaseIBA 02/2023
1	milademetanIBA 01/2023
1	gilteritinibIBA 12/2022
1	Asu(1,6)- argipressin (VAS-A)IBA 07/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Calcium-Binding ProteinsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	eltrombopag FDA Link 11/2021
1	pembrolizumabIBA 11/2021
1	LigandsIBA 11/2021
1	Interferon Type IIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	isavuconazoleIBA 01/2021
1	CPX-351IBA 11/2020
1	RetinoidsIBA 01/2020
1	RNA Helicases (RNA Helicase)IBA 01/2020
1	AcidsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	CR 6IBA 01/2020
1	IMP DehydrogenaseIBA 01/2020
1	midostaurinIBA 11/2019
1	HomoharringtonineIBA 01/2019
1	binimetinibIBA 01/2019
1	fms-Like Tyrosine Kinase 3IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	MitogensIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	DioxygenasesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Janus Kinase 2IBA 01/2019
1	LY2510924IBA 01/2018
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2018
1	fludarabineIBA 01/2018
1	Core Binding Factor Alpha 2 SubunitIBA 07/2017

Therapy/Procedure

14	Therapeutics 01/2023 - 01/2017
9	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
3	Drug Tapering 11/2021 - 01/2018
2	Induction Chemotherapy 11/2019 - 12/2016
1	Critical Care (Surgical Intensive Care) 07/2022
1	Esophagectomy 01/2022
1	Remission Induction 01/2021
1	Immunotherapy 01/2020